Reuters logo
BRIEF-Neos Therapeutics reports Q3 loss of $0.58/shr
November 8, 2017 / 2:29 PM / 14 days ago

BRIEF-Neos Therapeutics reports Q3 loss of $0.58/shr

Nov 8 (Reuters) - Neos Therapeutics Inc

* Neos Therapeutics reports third quarter 2017 financial results

* Q3 loss per share $0.58

* Q3 earnings per share view $-0.75 -- Thomson Reuters I/B/E/S

* Neos Therapeutics Inc - ‍total product revenues were $6.7 million for three months ended September 30, 2017, compared to $1.6 million for same period in 2016​

* Q3 earnings per share view $-0.75, revenue view $6.6 million -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below